Experts assess Trump’s 7-point healthcare planWe asked industry insiders to detail and analyze each component of Trump’s healthcare plan.
Do pay-for-delay agreements buy antitrust uncertainty?Agreements must be judged by antitrust’s rule of reason to determine true consequences.
Supreme Court rules against “pay-for-delay”The US Supreme Court today stated that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.
U.S. Supreme Court hears arguments on pay-for-delay settlementsThe U.S. Supreme Court will have to decide whether reverse payments, also known as “pay-for-delay settlements,” between branded and generic drug companies are anticompetitive and violate U.S. antitrust law.